Antiplatelet therapy in children

Area of Science:

• Cardiovascular Medicine
• Pediatric Thrombosis
• Pharmacology

Background:

• Platelets are vital for hemostasis but also contribute to atherosclerosis and arterial thrombosis.
• Antiplatelet drug use is well-established in adults for preventing thrombotic events.
• Limited evidence exists for antiplatelet therapy in pediatric populations.

Purpose of the Study:

• To review the current understanding of antiplatelet drug use in children.
• To identify knowledge gaps in pediatric arterial thrombosis management.
• To highlight the need for further research in this area.

Main Methods:

• Literature review of existing studies on antiplatelet therapy in pediatric populations.
• Analysis of current guidelines and clinical practices.
• Identification of specific pediatric conditions requiring antiplatelet therapy.

Main Results:

• Established protocols for antiplatelet use in adult cardiovascular and cerebrovascular disease prevention.
• Uncertainty regarding optimal antiplatelet strategies for pediatric ischemic stroke, Kawasaki disease, and post-cardiac surgery thromboembolism.
• Lack of exploration into newer antiplatelet agents for pediatric arterial thrombosis.

Conclusions:

• Current antiplatelet strategies in adults are well-defined but not directly applicable to children.
• Further clinical trials are necessary to establish the efficacy and safety of aspirin and anticoagulants in pediatric thrombosis.
• The role of novel antiplatelet drugs in pediatric arterial thrombosis remains an unexplored area.